Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Progesterone Dosing for Low Progesterone Levels

Introduction to Progesterone Regimens

  • The American College of Obstetricians and Gynecologists recommends starting with micronized progesterone (MP) 200 mg orally or vaginally for 12-14 days every 28 days when used sequentially with estrogen, or 100-200 mg daily for continuous regimens for women with low progesterone requiring hormone replacement therapy 1, 2

Sequential Regimen

  • Micronized progesterone is the preferred progestogen due to its superior cardiovascular and thromboembolism safety profile compared to synthetic progestins 2, 3
  • Oral or vaginal micronized progesterone: 200 mg daily for 12-14 days every 28 days when combined with continuous estrogen therapy 1, 2
  • Alternative dosing: 100 mg daily for 12-14 days per month is acceptable for lower-dose estrogen regimens 4

Alternative Progestins

  • Medroxyprogesterone acetate (MPA): 10 mg daily for 12-14 days per month 1, 2
  • Dydrogesterone: 10 mg daily for 12-14 days per month 2, 3
  • Norethisterone: 5 mg daily for 12-14 days per month 4

Continuous Combined Regimens

  • MPA: 2.5 mg daily continuously 2, 3
  • Dydrogesterone: 5 mg daily continuously 2, 3
  • Norethisterone: 1 mg daily continuously 2

Critical Timing Considerations

  • Progestin should only be added after 2-3 years of estrogen-only therapy in pubertal induction, or when breakthrough bleeding occurs 4
  • Confirm adequate endometrial thickness via ultrasound before initiating progestin 4
  • In post-pubertal women with established cycles, begin progestin immediately with estrogen therapy 1, 2

Important Caveats

  • Avoid progestins with anti-androgenic effects in women with low testosterone or sexual dysfunction, as they may worsen hypoandrogenism 2, 3
  • Do not confuse different progesterone formulations: Injectable 17-alpha-hydroxyprogesterone caproate (17P) 250 mg IM weekly is specifically for preterm birth prevention, not for general progesterone replacement 5

Monitoring and Duration

  • Continue hormone replacement therapy until the average age of natural menopause (45-55 years) 2, 3
  • Adjust dosing based on symptom control and tolerance rather than serum levels 2